Key Insights: 1. Find a great supporting mentors 2. Network beyond your bubble 3. Ignore “That’s impossible” talk—ask folks who actually DID it 4. Turn every scar into fuel for resilience & leadership.

Now there are 44 Cell gene therapies approved in the US - Hematology 23 - Oncology 6 - Neurology 5 - Dermatology 3 - Ophthalmology 2 - Others 5 Will we see a surge in the Oncology field based on what we are seeing at #ASCO2025 #ASCO25 #MedTwitter #MedEd OncoAlert USMIRC News

Behind the scenes at #ASCO25: Moffitt experts Ahmad Tarhini, MD, PhD (Ahmad Tarhini) and Richard Kim, MD, join OncLive.com, Oncology Now and Oncology Learning Network to share insights from ASCO. #MoffittASCO25

From #ASCO25: Ahmad Tarhini, MD, PhD, (Ahmad Tarhini) presents key findings from a meta-analysis of 12 RCTs in metastatic melanoma. The study shows a slight difference in progression-free survival assessments between local investigators and blinded independent central review.

Thanks for this platform Nazli & co. Grateful to be a part of it 🙏

Plenary session underway #ASCO25 Dr. Zon with the opening address

Woohoo 🙌🙌 You go Nazli Dizman 🥳🥳

Live from #ASCO25: Moffitt’s Andrew Kuykendall, MD, (Andrew Kuykendall MD) presents practice changing results from the VERIFY study, sharing that rusfertide significantly improves outcomes for patients with polycythemia vera. Key takeaways: • Phase 3 VERIFY study compared the hepcidin

Join Karun Neupane, MD, (Karun Neupane, MD), tomorrow at #ASCO25 as he shares research highlighting barriers for major career awards for international medical graduates. Read more: meetings.asco.org/2025-asco-annu… #MoffittASCO25 ASCO

Thank you Charmi for stepping up to present our team’s work from the ASCO IMG CoP Research and Publications Committee IMG Oncologists while I had to step away due to an urgent family matter. More in-depth IMG related data to follow in near future!!

Just out! New IMS/ IMWG Definition of High Risk Myeloma. Journal of Clinical Oncology #IMWG25 Myeloma Society International Myeloma Foundation Nikhil C. Munshi, MD marivi mateos Sagar Lonial MD Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Noopur Raje

Key Myeloma therapy update for 2025 1) Newly diagnosed: Start treatment with quads, if possible. (Dara-VRd or Isa-VRd). 2) Auto Transplant: can be deferred for standard risk patients, especially if good response to induction. But collect and store stem cells for future use.

✍️Mark your calendar for our next upcoming space‼️ Conquer Conversations; Navigating Career Development with Conquer Cancer Support🏆 Speaker: Julia Schwartz/Conquer Cancer, the ASCO Foundation Host: Noha N. Soror, MD, MSc. 𓂀 ⏰Tuesday, 1st July, 2025 📍Zoom, 17:30 pm EST (Scan QR code for registration)

Rising PGY-5s and anyone interested, we have a 5th HN rad onc position Moffitt Cancer Center. If interested in joining a busy team, including me, Dr. M Echevarria, George Q. Yang, MD, and Niema Razavian, MD, reach out and can chat about the position.

🚨Calling all applicants for the 2025 Hem/Onc Fellowship Match! Our Mentorship Program is now open for mentee sign-ups! Get paired with mentors for guidance on your application process! 👉Sign up here: tinyurl.com/dnu38ax4 OncoAlert ASCO TECAG Hem-Onc Fellows Network #IMGoncCoP

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes

✍️Mark your calendar for our next upcoming space❗️ Mastering the Eras Application - What to Focus On: Signaling and Experiences? ‼️ Speaker: Talal Hilal 🩺, Heme/Onc Fellowship PD at Mayo Clinic, Arizona Host: Stephanie A. Haddad, DO ⏰Wednesday, July 9th, 2025 📍X space, 7 pm EST

🔥🔥🔥

Great opportunity to discuss all the progress that we had last few years in rectal cancer.. join Moffitt Cancer Center team in this discussion! NCCN Tumor Board – Live Webinar Wednesday, September 17 @ 11 AM EDT Exploring Omission of Radiation Therapy in the Management of Rectal Cancer